CIM LLC’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$514K Sell
7,002
-4,374
-38% -$321K 0.07% 113
2025
Q1
$1.3M Sell
11,376
-924
-8% -$106K 0.19% 82
2024
Q4
$620K Sell
12,300
-3,143
-20% -$158K 0.09% 112
2024
Q3
$715K Sell
15,443
-466
-3% -$21.6K 0.1% 104
2024
Q2
$542K Buy
15,909
+130
+0.8% +$4.43K 0.08% 107
2024
Q1
$397K Buy
15,779
+129
+0.8% +$3.25K 0.06% 116
2023
Q4
$360K Buy
15,650
+1,411
+10% +$32.4K 0.06% 117
2023
Q3
$388K Buy
14,239
+187
+1% +$5.1K 0.07% 112
2023
Q2
$313K Buy
14,052
+350
+3% +$7.79K 0.06% 128
2023
Q1
$297K Sell
13,702
-345
-2% -$7.47K 0.06% 128
2022
Q4
$324K Sell
14,047
-333
-2% -$7.67K 0.06% 126
2022
Q3
$431K Buy
14,380
+996
+7% +$29.9K 0.09% 109
2022
Q2
$370K Buy
13,384
+3,678
+38% +$102K 0.08% 107
2022
Q1
$234K Buy
+9,706
New +$234K 0.04% 133
2018
Q4
Sell
-10,973
Closed -$154K 102
2018
Q3
$154K Buy
+10,973
New +$154K 0.06% 113